Anavex Life Sciences Corp. (AVXL) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$4.33
Day's range
$4.65

Anavex Life Sciences Corporation Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 02/12/2026 7.53 M $26.79 M   4.70% 8.45%
VANGUARD GROUP INC 01/29/2026 5.03 M $17.90 M   -1.49% 5.65%
STATE STREET CORP 02/13/2026 4.38 M $15.60 M   33.35% 4.92%
GEODE CAPITAL MANAGEMENT, LLC 02/09/2026 2.02 M $7.20 M   -0.22% 2.27%
TWO SIGMA INVESTMENTS, LP 02/17/2026 1.65 M $5.89 M   59.48% 1.86%
TWO SIGMA ADVISERS, LP 02/17/2026 1.21 M $4.31 M   59.47% 1.36%
NWAM LLC 02/04/2026 870.80 K $4.37 M   -0.40% 1.02%
SUMMIT FINANCIAL, LLC 02/13/2026 903.39 K $3.22 M   103.34% 1.01%
GOLDMAN SACHS GROUP INC 02/10/2026 872.97 K $3.11 M   187.74% 0.98%
JANE STREET GROUP, LLC 02/12/2026 768.96 K $2.74 M   252.38% 0.86%
NORTHERN TRUST CORP 02/17/2026 738.24 K $2.63 M   -4.50% 0.83%
CITADEL ADVISORS LLC 02/17/2026 707.30 K $2.52 M   80.85% 0.79%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/13/2026 668.96 K $2.38 M   -6.75% 0.75%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 576.70 K $2.05 M   -2.85% 0.65%
LPL FINANCIAL LLC 02/11/2026 528.78 K $1.88 M   -1.04% 0.59%
BANK OF AMERICA CORP /DE/ 02/17/2026 524.19 K $1.87 M   206.75% 0.59%
BARCLAYS PLC 02/13/2026 493.17 K $1.76 M   88.75% 0.55%
MORGAN STANLEY 02/13/2026 474.86 K $1.69 M   -15.23% 0.53%
UBS GROUP AG 01/29/2026 459.39 K $1.64 M   -6.62% 0.52%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 439.50 K $1.56 M   -27.21% 0.49%
PRIVATE ADVISOR GROUP, LLC 02/17/2026 419.80 K $1.49 M   -7.76% 0.47%
QUBE RESEARCH & TECHNOLOGIES LTD 02/17/2026 388.72 K $1.38 M   100.00% 0.44%
FEDERATED HERMES, INC. 02/12/2026 367.84 K $1.31 M   100.00% 0.41%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 364.50 K $1.30 M   -47.73% 0.41%
CAPTION MANAGEMENT, LLC 02/17/2026 354.84 K $1.26 M   100.00% 0.40%
NATIONAL BANK OF CANADA /FI/ 02/17/2026 305.20 K $1.09 M   -22.37% 0.34%
POINT72 ASSET MANAGEMENT, L.P. 02/17/2026 278.02 K $989.74 K   100.00% 0.31%
WELLINGTON MANAGEMENT GROUP LLP 02/17/2026 272.23 K $969.14 K   -5.74% 0.31%
BANK OF NEW YORK MELLON CORP 02/10/2026 244.06 K $868.84 K   -1.60% 0.27%
PVG ASSET MANAGEMENT CORP 01/30/2026 216.30 K $770.01 K   62.45% 0.25%
CITADEL ADVISORS LLC 02/17/2026 222.10 K $790.68 K   175.90% 0.25%
MARSHALL WACE, LLP 02/13/2026 182.19 K $648.60 K   0.00% 0.20%
NUVEEN, LLC 02/12/2026 168.38 K $599.42 K   0.00% 0.19%
SWISS NATIONAL BANK 02/12/2026 164.40 K $585.26 K   0.00% 0.18%
UBS ASSET MANAGEMENT AMERICAS INC 02/13/2026 162.12 K $577.16 K   0.04% 0.18%
RAFFERTY ASSET MANAGEMENT, LLC 02/13/2026 156.30 K $556.43 K   44.15% 0.18%
SCULPTOR CAPITAL LP 02/13/2026 155.90 K $555.00 K   0.00% 0.18%
GSA CAPITAL PARTNERS LLP 02/06/2026 155.88 K $555.00 K   147.11% 0.18%
AQR CAPITAL MANAGEMENT LLC 02/17/2026 149.82 K $533.34 K   434.37% 0.17%
APELLA CAPITAL, LLC 01/21/2026 138.01 K $491.30 K   38.67% 0.16%
DIADEMA PARTNERS LP 02/17/2026 140.60 K $500.54 K   0.57% 0.16%
WELLS FARGO & COMPANY/MN 02/13/2026 133.82 K $476.40 K   17.52% 0.15%
SHEETS SMITH WEALTH MANAGEMENT 01/20/2026 117.70 K $419.00 K   100.00% 0.14%
180 WEALTH ADVISORS, LLC 01/09/2026 117.38 K $417.87 K   172.75% 0.14%
ALLIANCEBERNSTEIN L.P. 02/17/2026 115.20 K $410.11 K   0.00% 0.13%
CITADEL ADVISORS LLC 02/17/2026 113.74 K $404.91 K   -41.89% 0.13%
RHUMBLINE ADVISERS 02/13/2026 107.40 K $382.35 K   -13.38% 0.12%
STIFEL FINANCIAL CORP 02/13/2026 101.02 K $359.63 K   95.05% 0.11%
XTX TOPCO LTD 02/17/2026 99.06 K $352.65 K   21.24% 0.11%
CANADA PENSION PLAN INVESTMENT BOARD 02/17/2026 95.90 K $341.40 K   100.00% 0.11%

Anavex Life Sciences Corporation institutional Ownership - FAQ's

During the previous two years, 238 institutional investors and hedge funds held shares of Anavex Life Sciences Corporation. The most heavily invested institutionals were:

BlackRock, Inc.: 7.53 M

VANGUARD GROUP INC: 5.03 M

STATE STREET CORP: 4.38 M

GEODE CAPITAL MANAGEMENT, LLC: 2.02 M

TWO SIGMA INVESTMENTS, LP: 1.65 M

TWO SIGMA ADVISERS, LP: 1.21 M

42.42% of Anavex Life Sciences Corporation stock is owned by institutional investors.

Institutional investors have bought a total of 46.45 M shares in the last 24 months. This purchase volume represents approximately $203.92 M in transactions.